Filing Details
- Accession Number:
- 0001562180-21-002390
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-22 17:31:35
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-22 17:31:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806431 | Andrew Hykes | C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-19 | 1,400 | $106.89 | 221,571 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-19 | 2,143 | $108.43 | 219,428 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-19 | 2,400 | $109.56 | 217,028 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-19 | 2,485 | $110.55 | 214,543 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-19 | 572 | $111.07 | 213,971 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,550 | Indirect | By Child 1 |
| Common Stock | 1,550 | Indirect | By Child 2 |
| Common Stock | 1,550 | Indirect | By Child 3 |
| Common Stock | 1,000 | Indirect | By Spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
- This transaction was executed in multiple trades at prices ranging from $106.72 to $107.30 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $107.91 to $108.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $108.97 to $109.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $109.98 to $110.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $110.99 to $111.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
